Personalized medicine does not immediately fit into the generic industry model of high-volume and low prices, given its goal of providing tailored treatments for a single patient. Still, Association for Accessible Medicines president and CEO Dan Leonard wants the industry to consider its options.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?